VITT and Second Doses of COVID-19 Vaccine

Joanne Lacy; Sue Pavord; Kevin E. Brown

doi:10.1056/NEJMc2118507

VITT and Second Doses of COVID-19 Vaccine

Joanne Lacy, Sue Pavord, Kevin E. Brown^*

^*Corresponding author for this work

UK Health Security Agency

Research output: Contribution to journal › Letter › peer-review

25 Citations (Scopus)

Abstract

Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.

Original language	English
Pages (from-to)	95
Number of pages	1
Journal	New England Journal of Medicine
Volume	386
Issue number	1
DOIs	https://doi.org/10.1056/NEJMc2118507
Publication status	Published - 22 Dec 2021

Bibliographical note

Funding Information: No funding information.

Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission.

Publisher Copyright: Copyright © 2022 Massachusetts Medical Society. All rights reserved.

Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. "VITT and Second Doses of Covid-19 Vaccine." New England Journal of Medicine 386.1 (2022): 95-95.

DOI: 10.1056/NEJMc2118507

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMc2118507

Cite this

@article{23e1525efe2a4b52aaa90ccc4dc31f2e,

title = "VITT and Second Doses of COVID-19 Vaccine",

abstract = "Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.",

author = "Joanne Lacy and Sue Pavord and Brown, {Kevin E.}",

note = "Funding Information: No funding information. Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission. Publisher Copyright: Copyright {\textcopyright} 2022 Massachusetts Medical Society. All rights reserved. Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. {"}VITT and Second Doses of Covid-19 Vaccine.{"} New England Journal of Medicine 386.1 (2022): 95-95. DOI: 10.1056/NEJMc2118507",

year = "2021",

month = dec,

day = "22",

doi = "10.1056/NEJMc2118507",

language = "English",

volume = "386",

pages = "95",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "1",

}

TY - JOUR

T1 - VITT and Second Doses of COVID-19 Vaccine

AU - Lacy, Joanne

AU - Pavord, Sue

AU - Brown, Kevin E.

N1 - Funding Information: No funding information. Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission. Publisher Copyright: Copyright © 2022 Massachusetts Medical Society. All rights reserved. Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. "VITT and Second Doses of Covid-19 Vaccine." New England Journal of Medicine 386.1 (2022): 95-95. DOI: 10.1056/NEJMc2118507

PY - 2021/12/22

Y1 - 2021/12/22

N2 - Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.

AB - Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=85122752259&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2118507

DO - 10.1056/NEJMc2118507

M3 - Letter

AN - SCOPUS:85122752259

SN - 0028-4793

VL - 386

SP - 95

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 1

ER -

VITT and Second Doses of COVID-19 Vaccine

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this